Thrombolytic therapy.
D000925:Anticoagulants / Q000009:adverse effects; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006801:Humans; D013300:Streptokinase / Q000009:adverse effects; D013927:Thrombosis / Q000188:drug therapy*
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D013300:Streptokinase